PKO Investment Management Joint-Stock’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.01M | Buy |
13,500
+11,700
| +650% | +$5.21M | 0.65% | 39 |
|
|
2025
Q1 | $873K | Sell |
1,800
-5,800
| -76% | -$2.81M | 0.1% | 134 |
|
|
2024
Q4 | $3.06M | Buy |
7,600
+5,800
| +322% | +$2.34M | 0.38% | 54 |
|
|
2024
Q3 | $837K | Buy |
1,800
+800
| +80% | +$372K | 0.1% | 121 |
|
|
2024
Q2 | $469K | Sell |
1,000
-4,000
| -80% | -$1.87M | 0.06% | 147 |
|
|
2024
Q1 | $2.1M | Hold |
5,000
| – | – | 0.25% | 71 |
|
|
2023
Q4 | $2.03M | Buy |
+5,000
| New | +$2.03M | 0.25% | 64 |
|
|
2023
Q2 | – | Sell |
-2,000
| Closed | -$630K | – | 149 |
|
|
2023
Q1 | $630K | Buy |
2,000
+800
| +67% | +$252K | 0.08% | 123 |
|
|
2022
Q4 | $347K | Hold |
1,200
| – | – | 0.05% | 125 |
|
|
2022
Q3 | $347K | Hold |
1,200
| – | – | 0.06% | 123 |
|
|
2022
Q2 | $338K | Sell |
1,200
-1,300
| -52% | -$366K | 0.05% | 116 |
|
|
2022
Q1 | $652K | Sell |
2,500
-4,500
| -64% | -$1.17M | 0.08% | 103 |
|
|
2021
Q4 | $1.54M | Buy |
+7,000
| New | +$1.54M | 0.17% | 85 |
|